On the basis of a monozygotic twin model, a study suggested that the demethylation of AMZ1 in DLPFC is associated with dyskinesia, another potential symptom of AD (Soerensen et al., 2019). This evidence concerns the gene AMZ1 and drug-induced dyskinesia.